• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成瘾与小脑:关注阿片受体的作用。

Addiction and the cerebellum with a focus on actions of opioid receptors.

机构信息

Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.

Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran.

出版信息

Neurosci Biobehav Rev. 2021 Dec;131:229-247. doi: 10.1016/j.neubiorev.2021.09.021. Epub 2021 Sep 20.

DOI:10.1016/j.neubiorev.2021.09.021
PMID:34555385
Abstract

Increasing evidence suggests that the cerebellum could play a role in the higher cognitive processes involved in addiction as the cerebellum contains anatomical and functional pathways to circuitry controlling motivation and saliency. In addition, the cerebellum exhibits a widespread presence of receptors, including opioid receptors which are known to play a prominent role in synaptic and circuit mechanisms of plasticity associated with drug use and development of addiction to opioids and other drugs of abuse. Further, the presence of perineural nets (PNNs) in the cerebellum which contain proteins known to alter synaptic plasticity could contribute to addiction. The role the cerebellum plays in processes of addiction is likely complex, and could depend on the particular drug of abuse, the pattern of use, and the stage of the user within the addiction cycle. In this review, we discuss functional and structural modifications shown to be produced in the cerebellum by opioids that exhibit dependency-inducing properties which provide support for the conclusion that the cerebellum plays a role in addiction.

摘要

越来越多的证据表明,小脑在成瘾相关的高级认知过程中可能发挥作用,因为小脑包含控制动机和突显的电路的解剖和功能途径。此外,小脑表现出广泛的受体存在,包括阿片受体,已知其在与药物使用和成瘾相关的突触和电路机制的可塑性中起重要作用,包括阿片类药物和其他滥用药物。此外,小脑中存在神经周网 (PNNs),其中包含已知可改变突触可塑性的蛋白质,这可能导致成瘾。小脑在成瘾过程中所起的作用可能很复杂,并且可能取决于特定的滥用药物、使用模式以及成瘾周期中使用者的阶段。在这篇综述中,我们讨论了表现出依赖性诱导特性的阿片类药物在小脑中产生的功能和结构改变,这为小脑在成瘾中发挥作用的结论提供了支持。

相似文献

1
Addiction and the cerebellum with a focus on actions of opioid receptors.成瘾与小脑:关注阿片受体的作用。
Neurosci Biobehav Rev. 2021 Dec;131:229-247. doi: 10.1016/j.neubiorev.2021.09.021. Epub 2021 Sep 20.
2
Why should we keep the cerebellum in mind when thinking about addiction?当思考成瘾问题时,为什么我们应该将小脑铭记于心?
Curr Drug Abuse Rev. 2009 Jan;2(1):26-40. doi: 10.2174/1874473710902010026.
3
Have we been ignoring the elephant in the room? Seven arguments for considering the cerebellum as part of addiction circuitry.我们是否一直忽视了房间里的那头大象?关于将小脑视为成瘾神经回路一部分的七个论据。
Neurosci Biobehav Rev. 2016 Jan;60:1-11. doi: 10.1016/j.neubiorev.2015.11.005. Epub 2015 Nov 19.
4
Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.通过 κ 型阿片受体,皮质纹状体突触的长时程可塑性受到特定通路中外源阿片共同释放的调节。
J Physiol. 2017 Aug 15;595(16):5637-5652. doi: 10.1113/JP274190. Epub 2017 May 26.
5
Opiates and Plasticity in the Ventral Tegmental Area.阿片类药物与腹侧被盖区的可塑性。
ACS Chem Neurosci. 2017 Sep 20;8(9):1830-1838. doi: 10.1021/acschemneuro.7b00281. Epub 2017 Aug 16.
6
Addiction-induced plasticity in underlying neural circuits.成瘾导致的潜在神经回路可塑性。
Neurol Sci. 2022 Mar;43(3):1605-1615. doi: 10.1007/s10072-021-05778-y. Epub 2022 Jan 22.
7
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.细胞对慢性阿片类药物的神经适应性变化:耐受性、戒断反应与成瘾
Br J Pharmacol. 2008 May;154(2):384-96. doi: 10.1038/bjp.2008.100. Epub 2008 Apr 14.
8
Cellular and molecular basis of drug addiction: The role of neuronal ensembles in addiction.药物成瘾的细胞和分子基础:神经元集合在成瘾中的作用。
Curr Opin Neurobiol. 2023 Dec;83:102813. doi: 10.1016/j.conb.2023.102813. Epub 2023 Nov 14.
9
Opioid Receptors.阿片受体。
Annu Rev Med. 2016;67:433-51. doi: 10.1146/annurev-med-062613-093100. Epub 2015 Aug 26.
10
Opioid addiction and the cerebellum.阿片成瘾与小脑。
Neurosci Biobehav Rev. 2019 Dec;107:238-251. doi: 10.1016/j.neubiorev.2019.09.015. Epub 2019 Sep 14.

引用本文的文献

1
Structural brain changes associated with cocaine use and digital cognitive behavioral therapy in cocaine use disorder treatment.与可卡因使用及可卡因使用障碍治疗中的数字认知行为疗法相关的大脑结构变化。
Drug Alcohol Depend Rep. 2024 Jun 2;11:100246. doi: 10.1016/j.dadr.2024.100246. eCollection 2024 Jun.
2
Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders.多部位慢性疼痛与物质使用障碍的多效性和遗传推断因果关系。
Mol Psychiatry. 2024 Jul;29(7):2021-2030. doi: 10.1038/s41380-024-02446-3. Epub 2024 Feb 15.
3
The Effect of Prenatal and Neonatal Fluoride Exposure to Morphine-Induced Neuroinflammation.
产前和新生儿期氟暴露对吗啡诱导的神经炎症的影响。
Int J Mol Sci. 2024 Jan 9;25(2):826. doi: 10.3390/ijms25020826.
4
Chemogenetic Perturbation of the Posterior But Not Anterior Cerebellum Reduces Voluntary Ethanol Consumption.基因药理学干扰小脑后部而非前部可减少自愿性乙醇摄取。
eNeuro. 2023 Sep 19;10(9). doi: 10.1523/ENEURO.0037-23.2023. Print 2023 Sep.
5
The effect of cannabidiol on seizure features and quality of life in drug-resistant frontal lobe epilepsy patients: a triple-blind controlled trial.大麻二酚对耐药性额叶癫痫患者癫痫发作特征及生活质量的影响:一项三盲对照试验。
Front Neurol. 2023 Jul 3;14:1143783. doi: 10.3389/fneur.2023.1143783. eCollection 2023.
6
Deep brain stimulation (DBS) as a therapeutic approach in gait disorders: What does it bring to the table?深部脑刺激(DBS)作为治疗步态障碍的一种方法:它有何作用?
IBRO Neurosci Rep. 2023 May 19;14:507-513. doi: 10.1016/j.ibneur.2023.05.008. eCollection 2023 Jun.
7
Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases.衰老相关神经行为和神经炎症性疾病中的小胶质细胞动力学。
J Neuroinflammation. 2022 Nov 17;19(1):273. doi: 10.1186/s12974-022-02637-1.
8
Alterations in the Proteome and Phosphoproteome Profiles of Rat Hippocampus after Six Months of Morphine Withdrawal: Comparison with the Forebrain Cortex.吗啡戒断六个月后大鼠海马蛋白质组和磷酸化蛋白质组图谱的变化:与前脑皮质的比较。
Biomedicines. 2021 Dec 31;10(1):80. doi: 10.3390/biomedicines10010080.